scispace - formally typeset
F

Freddie Bray

Researcher at International Agency for Research on Cancer

Publications -  452
Citations -  345102

Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.

Papers
More filters
Journal ArticleDOI

The ever-increasing importance of cancer as a leading cause of premature death worldwide.

TL;DR: The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death is examined in this article, with CVD leading in 70 countries and cancer leading in 57 countries.
Journal ArticleDOI

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

TL;DR: Worldwide cumulative coverage of publicly funded HPV immunisation programmes up to 2014 is quantified, and the potential impact on future cervical cancer cases and deaths is estimated.
Journal ArticleDOI

International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?

TL;DR: Findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, and indicate that those prevention measures require further endorsement in many countries.
Journal ArticleDOI

International Variation in Female Breast Cancer Incidence and Mortality Rates

TL;DR: Global trends in female breast cancer rates are decreasing in most high-income countries, despite increasing or stable incidence rates, and the increasing incidence and mortality rates in a number of countries are of concern, particularly those undergoing rapid changes in human development.
Journal ArticleDOI

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

TL;DR: Progress in cancer control over the study period was evident for stomach, colon, lung (in males), and ovarian cancer, and the impact of comorbidity are likely the main determinants of patient outcomes.